{ "items": [ "\n\n
\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Cardiovascular & metabolic\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n16 December 2021
\n \n \n \nLed by the University of Oxford, a team of UK-based researchers have today reported results of the largest ever study to compare the risks of cardiovascular events, such as myocarditis, pericarditis, and cardiac arrhythmia, between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the Oxford-AstraZeneca vaccine.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Clinical trials\n \n \n \n \n Public engagement & involvement\n \n \n\n \n\n\n
\n \n\n \n8 December 2021
\n \n \n \nResearchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications \u2013 partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Cancer\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n12 November 2021
\n \n \n \nA study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic.\r\n\r\nThe research, presented at the NCRI Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n\n \n\n\n
\n \n\n \n1 November 2021
\n \n \n \nAn international team of researchers, led from Centre for Evidence-based Medicine based in the Nuffield Department of Primary Care Health Sciences, University of Oxford, and funded by the World Health Organization and the National Institute for Health Research School for Primary Care Research, have today announced the findings from the most complete analysis of high-quality covid transmission studies in asymptomatic and pre-symptomatic people to date.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & appointments\n \n \n \n \n COVID-19\n \n \n\n \n\n\n
\n \n\n \n26 October 2021
\n \n \n \nResearchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Digital health & innovation\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n25 October 2021
\n \n \n \nResearchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & appointments\n \n \n \n \n COVID-19\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n11 October 2021
\n \n \n \nA collaboration which used anonymised GP records to identify 1.5m people most at risk from Covid-19 and prioritise them for vaccination has won the prestigious John Perry Prize for computing innovation in primary care.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n\n \n\n\n
\n \n\n \n28 September 2021
\n \n \n \nSmoking is highly likely to worsen the severity of COVID-19 and the risk of dying with the infection, finds a large study led by researchers from the University of Oxford and published online in the respiratory journal Thorax.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n23 September 2021
\n \n \n \nProfessor Julia Hippisley-Cox and her team have been Highly Commended in the \u2018Best use of technology in Patient Safety\u2019 category for the QCovid risk calculator at this year\u2019s Health Service Journal Patient Safety Awards.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n20 September 2021
\n \n \n \nNew algorithm predicts those most at risk of serious Covid-19 outcomes from 14 or more days after second vaccination dose, when substantial immunity is expected to have developed Authors hope this new risk tool will allow those who perceive risk to be high to make more informed decisions regarding shielding and potentially inform policy and clinical decisions on booster vaccine doses and monoclonal antibodies
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n\n \n\n\n
\n \n\n \n27 August 2021
\n \n \n \nOxford researchers have today announced the results of a blood clot study, suggesting lower risk with vaccine than infection.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n10 August 2021
\n \n \n \nResearch into the risk of hospital admission from COVID-19 is recognised with a \"Best Research Paper Award\" from the journal Heart.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & appointments\n \n \n \n \n COVID-19\n \n \n\n \n\n\n
\n \n\n \n19 July 2021
\n \n \n \nThe Nuffield Department of Primary Care Health Sciences is delighted to announce that it has been awarded \u00a3557,674 to investigate how families are managing to cope with \u2018long covid\u2019 and to understand how best they can be supported.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n\n \n\n\n
\n \n\n \n15 July 2021
\n \n \n \nThe results, from within the OpenSAFELY platform, are based on electronic health records for more than 17 million people registered with a general practice in England linked to hospital admission and mortality data.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n\n \n\n\n
\n \n\n \n15 July 2021
\n \n \n \nThe QCovid\u00ae-powered COVID-19 Population Risk Assessment, developed by a cross-organisational team and rolled across NHS England, has won the Florence Nightingale Award for Excellence in Healthcare Data Analytics.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Clinical trials\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n\n \n\n\n
\n \n\n \n5 July 2021
\n \n \n \nThe PRINCIPLE trial has been highly commended at the Health Data Research UK Awards for the way in which patient data is utilised so participants are contacted about the trial soon after receiving a positive test result.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n\n \n\n\n
\n \n\n \n30 June 2021
\n \n \n \nGood data on Long COVID will be crucial for research into the prevalence of Long COVID, its causes and consequences, and to plan services effectively, say researchers following their analysis of 96% of electronic healthcare records in England using the OpenSAFELY platform.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Clinical trials\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n\n \n\n\n
\n \n\n \n23 June 2021
\n \n \n \nFrom today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world\u2019s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n DPhil\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n\n \n\n\n
\n \n\n \n21 June 2021
\n \n \n \nThere are higher proportions of ethnic minority children in England testing positive for COVID-19 than white children, with Asian children more likely to be admitted to hospital with the illness, finds an observational analysis of 2.6 million healthcare records led by Oxford University researchers.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Clinical trials\n \n \n\n \n\n\n
\n \n\n \n20 May 2021
\n \n \n \nEach year, International Clinical Trials Day recognises the people who conduct clinical trials, giving our community a chance to say thank you for everything they do to improve public health. This year our trials unit staff are sharing what makes them proud to be part of Oxford\u2019s Primary Care Clinical Trials Unit.
\n \n\n \n \n